Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Hans van der Putten"'
Autor:
Angela A.G. van Tilborg, William J. Brands, Brenda M. Pijlman, Dorry Boll, M. Caroline Vos, Toin H. van Kuppevelt, Hans van der Putten, Leon F.A.G. Massuger, Anneke A. M. van der Wurff, Dennis van Hamont
Publikováno v:
Disease markers. Section A, Cancer biomarkers, 25, 3, pp. 233-241
Disease markers. Section A, Cancer biomarkers, 25, 233-241
Disease markers. Section A, Cancer biomarkers, 25, 233-241
BACKGROUND Functional polymorphisms in matrix metalloproteinases can increase or decrease the risk of cancer. This study focused on ovarian cancer and investigated how polymorphisms in the coding region of MMP-14 and the promoter region of MMP-2 are
Autor:
Katja N. Gaarenstroom, Neil K. Aaronson, Marc van Beurden, Eleonora B.L. van Dorst, Eveline M. A. Bleiker, Marian J.E. Mourits, Jacobien M. Kieffer, R F M Vermeulen, Heiddis B. Valdimarsdottir, Hans van der Putten, Leon F.A.G. Massuger
Publikováno v:
European Journal of Cancer, 84, 159-167
European Journal of Cancer, 84, pp. 159-167
European Journal of Cancer, 84, 159-167. Elsevier
European Journal of Cancer, 84, 159-167. ELSEVIER SCI LTD
European Journal of Cancer, 84, pp. 159-167
European Journal of Cancer, 84, 159-167. Elsevier
European Journal of Cancer, 84, 159-167. ELSEVIER SCI LTD
Contains fulltext : 182500.pdf (Publisher’s version ) (Closed access) BACKGROUND: There has been some doubts raised in earlier studies about the efficacy of hormone replacement therapy (HRT) in reducing endocrine and sexual problems in women who ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e7dde18c02a76a6cbdb6f7ec9d35dbc
https://hdl.handle.net/1887/115425
https://hdl.handle.net/1887/115425
Autor:
MC Vos, Dorry Boll, Harry Feijen, Toin H. van Kuppevelt, Brenda M. Pijlman, Anneke A. M. van der Wurff, Hans van der Putten, Leon F.A.G. Massuger, Nicole P. M. Ezendam, Paul J. J. M. Klinkhamer, Eva Hollemans
Publikováno v:
Journal of Ovarian Research, 9(1):53. BioMed Central
Journal of Ovarian Research, 9, 53-53
Journal of Ovarian Research
Journal of Ovarian Research, 9, 1, pp. 53-53
Journal of Ovarian Research, 9, 53-53
Journal of Ovarian Research
Journal of Ovarian Research, 9, 1, pp. 53-53
BackgroundTo investigate the expression of MMP-14 and CD44 as well as epithelial-to-mesenchymal transition(EMT)-like changes in ovarian cancer and to determine correlations with clinical outcome.MethodsIn 97 patients with ovarian cancer, MMP-14 and C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34420c5e518785f8971e4bac305952d1
https://research.tilburguniversity.edu/en/publications/f3291fe1-89eb-4034-b72a-e8dd89e2a86e
https://research.tilburguniversity.edu/en/publications/f3291fe1-89eb-4034-b72a-e8dd89e2a86e
Autor:
Ate G. van der Zee, Anca C Ansink, Wim J. Sluiter, Ignace Vergote, René H.M. Verheijen, Eleonora B.L. van Dorst, Katja N. Gaarenstroom, Jacobus van der Velden, Bettien M. van Hemel, Joanne A. de Hullu, Ralph H. Hermans, Harry Hollema, Angelo Maggioni, Peter Baldwin, Hans van der Putten, Pierre Drouin, Maaike H. M. Oonk, Ingo B. Runnebaum
Publikováno v:
The Lancet Oncology, 11(7), 646-652
Lancet Oncology, 11(7), 646-652. Lancet Publishing Group
Lancet Oncology, 11, 646-52
Lancet Oncology, 11(7), 646-652. ELSEVIER SCIENCE INC
Lancet Oncology, 11, 7, pp. 646-52
lancet oncology, 11(7), 646-652. Lancet Publishing Group
Oonk, M H, van Hemel, B M, Hollema, H, de Hullu, J A, Ansink, AC, Vergote, I, Verheijen, R H M, Maggioni, A, Gaarenstroom, K N, Baldwin, P J, van Dorst, E B, van der Velden, J, Hermans, R H, van der Putten, H W, Drouin, P, Runnebaum, I B, Sluiter, W J & van der Zee, A G 2010, ' Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study ', Lancet Oncology, vol. 11, no. 7, pp. 646-652 . https://doi.org/10.1016/S1470-2045(10)70104-2
Lancet Oncology, 11(7), 646-652. Lancet Publishing Group
Lancet Oncology, 11, 646-52
Lancet Oncology, 11(7), 646-652. ELSEVIER SCIENCE INC
Lancet Oncology, 11, 7, pp. 646-52
lancet oncology, 11(7), 646-652. Lancet Publishing Group
Oonk, M H, van Hemel, B M, Hollema, H, de Hullu, J A, Ansink, AC, Vergote, I, Verheijen, R H M, Maggioni, A, Gaarenstroom, K N, Baldwin, P J, van Dorst, E B, van der Velden, J, Hermans, R H, van der Putten, H W, Drouin, P, Runnebaum, I B, Sluiter, W J & van der Zee, A G 2010, ' Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study ', Lancet Oncology, vol. 11, no. 7, pp. 646-652 . https://doi.org/10.1016/S1470-2045(10)70104-2
Contains fulltext : 89256.pdf (Publisher’s version ) (Closed access) BACKGROUND: Currently, all patients with vulvar cancer with a positive sentinel node undergo inguinofemoral lymphadenectomy, irrespective of the size of sentinel-node metastases.
Autor:
Eleonore B. Van Dorst, Maaike H. M. Oonk, Katja N. Gaarenstroom, Ate G.J. van der Zee, Pierre Drouin, René H.M. Verheijen, Ignace Vergote, Ralph H. Hermans, Hans van der Putten, Anca C. Ansink, Jacobus van der Velden, Achim Schneider, Joanne A. de Hullu, Angelo Maggioni, Peter Baldwin, Wim J. Sluiter
Publikováno v:
Journal of Clinical Oncology, 26(6), 884-889. American Society of Clinical Oncology
Journal of clinical oncology, 26(6), 884-889. American Society of Clinical Oncology
van der Zee, A G, Oonk, M H, de Hullu, J A, Ansink, AC, Vergote, I, Verheijen, R H M, Maggioni, A, Gaarenstroom, K N, Baldwin, P J, van Dorst, E B, van, D V, Hermans, R H, van der Putten, H, Drouin, P, Schneider, A & Sluiter, W J 2008, ' Sentinel node dissection is safe in the treatment of early-stage vulvar cancer ', Journal of Clinical Oncology, vol. 26, no. 6, pp. 884-889 . https://doi.org/10.1200/JCO.2007.14.0566
Journal of Clinical Oncology, 26(6), 884-889. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 26, 6, pp. 884-9
Journal of Clinical Oncology, 26, 884-9
Journal of clinical oncology, 26(6), 884-889. American Society of Clinical Oncology
van der Zee, A G, Oonk, M H, de Hullu, J A, Ansink, AC, Vergote, I, Verheijen, R H M, Maggioni, A, Gaarenstroom, K N, Baldwin, P J, van Dorst, E B, van, D V, Hermans, R H, van der Putten, H, Drouin, P, Schneider, A & Sluiter, W J 2008, ' Sentinel node dissection is safe in the treatment of early-stage vulvar cancer ', Journal of Clinical Oncology, vol. 26, no. 6, pp. 884-889 . https://doi.org/10.1200/JCO.2007.14.0566
Journal of Clinical Oncology, 26(6), 884-889. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 26, 6, pp. 884-9
Journal of Clinical Oncology, 26, 884-9
Purpose To investigate the safety and clinical utility of the sentinel node procedure in early-stage vulvar cancer patients. Patients and Methods A multicenter observational study on sentinel node detection using radioactive tracer and blue dye was p
Autor:
Yvette P. Geels, Louis J.M. van der Putten, Nicole P. M. Ezendam, Hans van der Putten, Johanna M.A. Pijnenborg, Marc P.M.L. Snijders, Lonneke V. van de Poll-Franse
Publikováno v:
International Journal of Gynecological Cancer, 25, 75-80
International Journal of Gynecological Cancer, 25, 1, pp. 75-80
International Journal of Gynecological Cancer, 25(1). Lippincott Williams and Wilkins
International Journal of Gynecological Cancer, 25, 1, pp. 75-80
International Journal of Gynecological Cancer, 25(1). Lippincott Williams and Wilkins
ObjectivesTreatment of clinical early-stage endometrioid endometrial cancer (EEC) in The Netherlands consists of primary hysterectomy and bilateral salpingo-oophorectomy. Adjuvant radiotherapy is given when 2 or more the following risk factors are pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e92a45a5dfa828d1fdc4cc718557459e
http://hdl.handle.net/2066/153324
http://hdl.handle.net/2066/153324
Autor:
Ko van der Velden, Eveline M. A. Bleiker, Hans van der Putten, Leon F.A.G. Massuger, Marc van Beurden, Eleonora B.L. van Dorst, H. Boonstra, Marian J.E. Mourits, Judith Hollenstein, Katja N. Gaarenstroom, Heiddis B. Valdimarsdottir, René H.M. Verheijen, Joanna B. Madalinska, Neil K. Aaronson
Publikováno v:
Journal of clinical oncology, 24(22), 3576-3582. American Society of Clinical Oncology
Journal of Clinical Oncology, 24, 22, pp. 3576-82
Journal of Clinical Oncology, 24, 3576-82
Journal of Clinical Oncology, 24(22), 3576-3582. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 24, 22, pp. 3576-82
Journal of Clinical Oncology, 24, 3576-82
Journal of Clinical Oncology, 24(22), 3576-3582. AMER SOC CLINICAL ONCOLOGY
Purpose Preventive health strategies for women at increased hereditary risk of ovarian cancer include gynecologic screening (GS) and/or prophylactic oophorectomy (PBSO). Hormone replacement therapy (HRT) is often prescribed to compensate for postsurg
Autor:
Neil K. Aaronson, H. Boonstra, Eleonora B.L. van Dorst, Marc van Beurden, Katja N. Gaarenstroom, Eveline M. A. Bleiker, Joanna B. Madalinska, Lottie A.C. Lubsen-Brandsma, Heiddis B. Valdimarsdottir, Hans van der Putten, Marian J.E. Mourits, Leon F.A.G. Massuger
Publikováno v:
Journal of Clinical Oncology, 25(3), 301-307. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 25, 3, pp. 301-7
Journal of clinical oncology, 25(3), 301-307. American Society of Clinical Oncology
Journal of Clinical Oncology, 25, 301-7
Journal of Clinical Oncology, 25, 3, pp. 301-7
Journal of clinical oncology, 25(3), 301-307. American Society of Clinical Oncology
Journal of Clinical Oncology, 25, 301-7
Purpose Women with BRCA1/2 gene mutations who have completed their childbearing are strong candidates for risk-reducing prophylactic bilateral salpingo-oophorectomy (PBSO). The aim of the current study was to identify baseline predictors of PBSO vers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45a7781b7ca4f2dc6c0f7f783639556b
https://research.rug.nl/en/publications/e2f7fcec-7071-45a5-8bd6-3277c5c47eaf
https://research.rug.nl/en/publications/e2f7fcec-7071-45a5-8bd6-3277c5c47eaf
Autor:
Eleonora B.L. van Dorst, H. Boonstra, Marc van Beurden, Joanna B. Madalinska, Hans van der Putten, Leon F.A.G. Massuger, Heiddis B. Valdimarsdottir, Katja N. Gaarenstroom, Eveline M. A. Bleiker, René H.M. Verheijen, Neil K. Aaronson, Ko van der Velden, Judith Hollenstein, Marian J.E. Mourits
Publikováno v:
Journal of Clinical Oncology, 23, 28, pp. 6890-8
Journal of clinical oncology, 23(28), 6890-6898. American Society of Clinical Oncology
Journal of Clinical Oncology, 23, 6890-8
Journal of Clinical Oncology, 23(28), 6890-6898. AMER SOC CLINICAL ONCOLOGY
Journal of clinical oncology, 23(28), 6890-6898. American Society of Clinical Oncology
Journal of Clinical Oncology, 23, 6890-8
Journal of Clinical Oncology, 23(28), 6890-6898. AMER SOC CLINICAL ONCOLOGY
Purpose Recommendations for women at high risk of ovarian cancer include periodic gynecologic screening (GS) and prophylactic bilateral salpingo-oophorectomy (PBSO). The aim of the current study was to determine the quality-of-life (QOL) effects of P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0362e1cd2c0c552696a2789d6250d53e
https://hdl.handle.net/2066/48419
https://hdl.handle.net/2066/48419
Autor:
Thomas B.J. Demeyere, Geert-Jan Creemers, Hans van der Putten, Johanna M.A. Pijnenborg, Jeanette van Leeuwen
Publikováno v:
Gynecologic Oncology. 121:418-419